JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
GYRE - Gyre Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary GYRE Stock
Financials
Financials GYRE Stock
Loading...
Loading...
Income Statement
Income Statement GYRE Stock
Balance Sheet
Balance Sheet GYRE Stock
Cash Flow Statement
Cash Flow Statement GYRE Stock
Loading...
Loading...
GYRE Financials - Gyre Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Gyre Therapeutics, Inc. (GYRE)
Financials
Financials of GYRE
Loading...
Loading...
Loading...
Loading...
Revenue
$116.588M
Operating Income
$11.487M
Net Income
$9.88M
Share Count (Basic)
89.344622M
Operating Cash Flow
$1.01M
Free Cash Flow
$-180K
Cash And Short-Term Equivalents
$52.425M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
100M
120M
FY2021
FY2022
Revenue $USD
0
10M
20M
30M
40M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-80M
-60M
-40M
-20M
0
20M
Annual
Quarterly
Margins
Gross
Operating
Net
-1000%
-500%
0%
FY2023
FY2024
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-10M
-5M
0
5M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-50%
0%
50%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26